255 related articles for article (PubMed ID: 30671213)
1. Bortezomib Maintenance for the Treatment of Monoclonal Gammopathy of Renal Significance.
Lee H; Duggan P; Neri P; Tay J; Jimenez-Zepeda VH
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019007. PubMed ID: 30671213
[TBL] [Abstract][Full Text] [Related]
2. Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature review.
van Kruijsdijk RCM; Abrahams AC; Nguyen TQ; Minnema MC; Jacobs JFM; Limper M
J Nephrol; 2020 Jun; 33(3):611-617. PubMed ID: 32221859
[TBL] [Abstract][Full Text] [Related]
3. PGNMID and anti-CD38 monoclonal antibody: a therapeutic challenge.
Rahbari E; Barreca A; Nicolino B; Ciochetto C; Piraina V; Maroni S; Deagostini MC; Patti R; Bertucci P; Savoldi S
G Ital Nefrol; 2022 Feb; 39(1):. PubMed ID: 35191627
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R; Chatterjee T; Mendonca S; Dogra M; Pramanik SK; Yanamandra U
Saudi J Kidney Dis Transpl; 2021; 32(2):298-306. PubMed ID: 35017322
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report.
Noto R; Kamiura N; Ono Y; Tabata S; Hara S; Yokoi H; Yoshimoto A; Yanagita M
BMC Nephrol; 2017 Apr; 18(1):127. PubMed ID: 28385149
[TBL] [Abstract][Full Text] [Related]
6. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.
Bridoux F; Javaugue V; Nasr SH; Leung N
Nephrol Dial Transplant; 2021 Jan; 36(2):208-215. PubMed ID: 33494099
[TBL] [Abstract][Full Text] [Related]
7. An update to the pathogenesis for monoclonal gammopathy of renal significance.
Zuo C; Zhu Y; Xu G
Crit Rev Oncol Hematol; 2020 May; 149():102926. PubMed ID: 32199132
[TBL] [Abstract][Full Text] [Related]
8. Rhabdomyolysis and Acute Renal Dysfunction as Initial Manifestations of Monoclonal Gammopathy of Renal Significance.
Gudapati P; Al-Sultani A; Parmar A; Motwani R; Fortkort P
Cureus; 2023 Feb; 15(2):e34759. PubMed ID: 36909104
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathologic characteristics of kidney diseases related to monotypic IgA deposits.
Vignon M; Cohen C; Faguer S; Noel LH; Guilbeau C; Rabant M; Higgins S; Hummel A; Hertig A; Francois H; Lequintrec M; Vilaine E; Knebelmann B; Pourrat J; Chauveau D; Goujon JM; Javaugue V; Touchard G; El Karoui K; Bridoux F
Kidney Int; 2017 Mar; 91(3):720-728. PubMed ID: 28069266
[TBL] [Abstract][Full Text] [Related]
10. Light chain only variant of proliferative glomerulonephritis with monoclonal immunoglobulin deposits is associated with a high detection rate of the pathogenic plasma cell clone.
Nasr SH; Larsen CP; Sirac C; Theis JD; Domenger C; Chauvet S; Javaugue V; Hogan JJ; Said SM; Dasari S; Vrana JA; McPhail ED; Cornell LD; Vilaine E; Massy ZA; Boffa JJ; Buob D; Toussaint S; Guincestre T; Touchard G; D'Agati VD; Leung N; Bridoux F
Kidney Int; 2020 Mar; 97(3):589-601. PubMed ID: 32001067
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
Sethi S; Fervenza FC; Rajkumar SV
Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal Immunoglobulin Deposition Disease and Related Diseases.
Kanzaki G; Okabayashi Y; Nagahama K; Ohashi R; Tsuboi N; Yokoo T; Shimizu A
J Nippon Med Sch; 2019; 86(1):2-9. PubMed ID: 30918151
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options.
Amaador K; Peeters H; Minnema MC; Nguyen TQ; Dendooven A; Vos JMI; Croockewit AJ; van de Donk NWCJ; Jacobs JFM; Wetzels JFM; Sprangers B; Abrahams AC
Neth J Med; 2019 Sep; 77(7):243-254. PubMed ID: 31582582
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of monoclonal gammopathy of renal significance.
Bridoux F; Leung N; Hutchison CA; Touchard G; Sethi S; Fermand JP; Picken MM; Herrera GA; Kastritis E; Merlini G; Roussel M; Fervenza FC; Dispenzieri A; Kyle RA; Nasr SH;
Kidney Int; 2015 Apr; 87(4):698-711. PubMed ID: 25607108
[TBL] [Abstract][Full Text] [Related]
15. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits triggered by COVID-19: a case report.
Shieh M; Giannini JA; Combs SA; Shaffi SK; Messias NC; Teixeira JP
CEN Case Rep; 2022 Aug; 11(3):380-385. PubMed ID: 35122206
[TBL] [Abstract][Full Text] [Related]
16. An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
Li M; Xu G
Clin Kidney J; 2022 Jun; 15(6):1041-1048. PubMed ID: 35664272
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen.
Quattrocchio G; Barreca A; Vaccarino A; Del Vecchio G; De Simone E; Fenoglio R; Ferro M; Pagliaro M; Pini M; Manes M; Roccatello D
Front Med (Lausanne); 2020; 7():587345. PubMed ID: 33392216
[TBL] [Abstract][Full Text] [Related]
18. Updates in Plasma Cell Dyscrasias and Related Monoclonal Immunoglobulin-Mediated Renal Disease.
Midha S; Nadeem O; Selamet U
Semin Nephrol; 2022 Nov; 42(6):151352. PubMed ID: 37257390
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal gammopathy-associated proliferative glomerulonephritis.
Sethi S; Rajkumar SV
Mayo Clin Proc; 2013 Nov; 88(11):1284-93. PubMed ID: 24182705
[TBL] [Abstract][Full Text] [Related]
20. Proliferative Glomerulonephritis With Monoclonal IgG3λ Deposits: A Case Report of a Rare Cause of Monoclonal Gammopathy of Renal Significance.
Yu XJ; Wang MJ; Yong ZH; Ma YY; Wang SX; Zhou FD; Zhao MH
Kidney Med; 2019; 1(4):221-225. PubMed ID: 32734203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
